Systolic blood pressure for African-American patients dropped between one to five points when they moved to less segregated neighborhoods, according to a new study.
Browsing: Clinical Breakthroughs
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
Veterans Affairs hospitals outperformed civilian hospitals on most measures of quality and patient safety, but scored lower on indicators of patient experience, according to new Northwestern Medicine research.
Hans Breiter, ’88 MD, professor of Psychiatry and Behavioral Sciences, is leading the development of a radical, proactive approach to stopping violence using advanced mathematical models of human emotion.
A Northwestern Medicine study research shows people with no major heart disease risk factors in middle age live and stay healthy longer than others.
A combination of ultrasound and cystoscopy is the most cost-effective approach to detecting cancer in patients who show microscopic amounts of blood in their urine, according to a JAMA Internal Medicine study.
OncoSET, the flagship clinical and research program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, combines oncology with genomic sequencing to provide cutting-edge cancer care personalized for each patient.
Women who underwent autologous breast reconstruction following a mastectomy reported greater psychosocial and sexual well-being than those who chose implant-based reconstruction, according to a study published in the Journal of Clinical Oncology.
Americans of South Asian descent are twice as likely as whites to have risks for heart disease, stroke and diabetes, when their weight is in the normal range, according to a recent study.
Northwestern medicine scientist have shown how a medical device that delivers alternating electrical fields in addition to traditional chemotherapy can improve survival for patients with glioblastoma.